These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14520947)

  • 1. [Dynamics of a 24-h profile of arterial pressure and function of the vascular endothelium in nebivolol treatment of hypertensive patients].
    Gel'tser BI; Kotel'nikov VN
    Klin Med (Mosk); 2003; 81(8):53-6. PubMed ID: 14520947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional and biochemical characteristics of the vasodilator effects of nebivolol in patients with arterial hypertension].
    Gel'tser BI; Kotel'niko v VN; Savchenko SV
    Ter Arkh; 2002; 74(12):34-7. PubMed ID: 12577837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
    Buval'tsev VI; Spasskaia MB; Nebieridze DV; Metel'skaia VA; Guseva OI
    Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of nebivolol in patients with mild and moderate hypertension].
    Zhigunova LV; Lakhova EL; Iurenev AP
    Ter Arkh; 2003; 75(3):59-61. PubMed ID: 12718224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP; Zinchuk VV
    Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of nebivolol on endothelial dysfunction in salt-sensitive hypertension.
    Ugrekhelidze J; Simonia G; Andronikashvili I; Kutateladze M
    Georgian Med News; 2006 Apr; (133):56-8. PubMed ID: 16705229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nebivolol effects on the cardiovascular system and the kidneys in pregnant and puerperal women with hypertension].
    Tkacheva ON; Vertkin AL; Barabashkina AV; Vasil'eva AV; Razguliaeva NF
    Ter Arkh; 2006; 78(10):56-61. PubMed ID: 17180940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D; Papademetriou V
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity.
    Mason RP; Kubant R; Jacob RF; Walter MF; Boychuk B; Malinski T
    J Cardiovasc Pharmacol; 2006 Jul; 48(1):862-9. PubMed ID: 16891916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of nebivolol on endothelial function in obese patients with hypertension].
    Kovaleva ON; Demidenko AV
    Lik Sprava; 2006 Jun; (4):57-61. PubMed ID: 17100242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats.
    Toblli JE; Cao G; Casas G; Mazza ON
    Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
    Tuncer M; Guntekin U; Gunes Y; Gumrukcuoglu HA; Eryonucu B
    Adv Ther; 2008 Jun; 25(6):619-26. PubMed ID: 18563311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy.
    Galetta F; Franzoni F; Magagna A; Femia FR; Pentimone F; Santoro G; Carpi A
    Biomed Pharmacother; 2005; 59(1-2):15-9. PubMed ID: 15740930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.
    Agabiti Rosei E; Rizzoni D
    Drugs; 2007; 67(8):1097-107. PubMed ID: 17521213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator effects of nebivolol in a rat model of hypertension and a rabbit model of congestive heart failure.
    de Groot AA; Mathy MJ; van Zwieten PA; Peters SL
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):56-60. PubMed ID: 17666916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.
    Celik T; Iyisoy A; Kursaklioglu H; Kardesoglu E; Kilic S; Turhan H; Yilmaz MI; Ozcan O; Yaman H; Isik E; Fici F
    J Hypertens; 2006 Mar; 24(3):591-6. PubMed ID: 16467663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring vascular benefits of endothelium-derived nitric oxide.
    Cockcroft JR
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):177S-183S. PubMed ID: 16373196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of nebivolol, metoprolol and enalapril maleate on the state of endothelium-dependent arteriolar vasodilation in patients with essential hypertension].
    Polivoda SN; Cherepok AA; Solov'iuk AO; Sychev RA; Kurilo OA
    Lik Sprava; 2001; (2):138-40. PubMed ID: 11519414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.